Scholarlink

<p><i>Mycoplasma ovipneumoniae</i> (MO) and Ovine parainfluenza virus type 3 (OPIV3) are significant pathogens implicated in ovine respiratory diseases, which impose substantial threats to extensive sheep farming. However, no commercial bivalent vaccines targeting both pathogens are currently available. In this study, we constructed a recombinant live-attenuated OPIV3 using Red/ET recombination, inserting MO adhesion protein genes (P60, P113) between the N and P genes of the OPIV3 genome. The recombinant candidate rOPIV3-MO was successfully generated and inhibited growth kinetics similar to those of the parental OPIV3 TJ2022 strain. Immunization trials in sheep indicated that rOPIV3-MO displayed a favorable safety profile. Both rOPIV3-MO and OPIV3 TJ2022 inoculation induced specific and neutralizing antibodies, as well as T-cell receptor (TCR) rearrangements.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Construction of recombinant OPIV3 virus vectoring bivalent Mycoplasma ovipneumoniae adhesins

  • 期刊论文

  • 发表日期：

    2026年2月19日

查看全文
  • Xu Zhang,
  • Yijia Liu,
  • Boxuan Yin,
  • Changyan Li,
  • Miao sun,
  • Qinghong Xue,
  • Jinhai Huang

摘要

Mycoplasma ovipneumoniae (MO) and Ovine parainfluenza virus type 3 (OPIV3) are significant pathogens implicated in ovine respiratory diseases, which impose substantial threats to extensive sheep farming. However, no commercial bivalent vaccines targeting both pathogens are currently available. In this study, we constructed a recombinant live-attenuated OPIV3 using Red/ET recombination, inserting MO adhesion protein genes (P60, P113) between the N and P genes of the OPIV3 genome. The recombinant candidate rOPIV3-MO was successfully generated and inhibited growth kinetics similar to those of the parental OPIV3 TJ2022 strain. Immunization trials in sheep indicated that rOPIV3-MO displayed a favorable safety profile. Both rOPIV3-MO and OPIV3 TJ2022 inoculation induced specific and neutralizing antibodies, as well as T-cell receptor (TCR) rearrangements.